Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Compass Therapeutics (CMPX) Return on Equity (2023 - 2025)

Historic Return on Equity for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to 0.46%.

  • Compass Therapeutics' Return on Equity fell 1100.0% to 0.46% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.46%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.41% for FY2024, which is N/A changed from last year.
  • Compass Therapeutics' Return on Equity amounted to 0.46% in Q3 2025, which was down 1100.0% from 0.65% recorded in Q2 2025.
  • Over the past 5 years, Compass Therapeutics' Return on Equity peaked at 0.28% during Q4 2023, and registered a low of 0.65% during Q2 2025.
  • Moreover, its 3-year median value for Return on Equity was 0.37% (2024), whereas its average is 0.41%.
  • Data for Compass Therapeutics' Return on Equity shows a peak YoY increase of -1100bps (in 2025) and a maximum YoY decrease of -3400bps (in 2025) over the last 5 years.
  • Over the past 3 years, Compass Therapeutics' Return on Equity (Quarter) stood at 0.28% in 2023, then plummeted by -45bps to 0.4% in 2024, then decreased by -16bps to 0.46% in 2025.
  • Its Return on Equity stands at 0.46% for Q3 2025, versus 0.65% for Q2 2025 and 0.5% for Q1 2025.